Treatment of a prostate cancer cell line with NKp30-Ig reduced cancer growth, and macrophages activated against NKp30-Ig-coated cells mediated antibody-dependent cell cytotoxicity (ADCC) [79]. The gene discussed is NCR3; the disease is prostate cancer.